News & Analysis on Clinical Trial Services & Contract Research And Development
Proposed law changes put before the US Senate and the House of Representatives last week seek to eliminate duplicate trials and force sponsors to display all results on Clinical trials.gov website.
Results season is well under way and in-PharmaTechnologist.com is here to bring you the latest as companies announce their chops, changes and plans for the coming quarters.
The Chinese Food and Drug Administration (SFDA) has confirmed that drugmakers and suppliers will take on more responsibility for ensuring excipient quality under new provisions.
West Pharmaceutical Services is sticking with plans to lessen CMO (contract manufacturing organisation) activities and boost proprietary products despite a hefty uptick in contract production in Q2.
The CMO producing Natpara for NPS Pharmaceuticals has hit problems just as the company was preparing to submit its BLA.